Advertisement
Screener

APTALIS PHARMA INC Income Tax Expense

APTALIS PHARMA INC Income Tax Expense

APTALIS PHARMA INC reported Income Tax Expense of -$1.31 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.

Discontinued › Expense Statement

us-gaap:IncomeTaxExpenseBenefit · last filed 2012-02-10

  • APTALIS PHARMA INC income tax expense (benefit) for the quarter ending 2011-12-31 was -$1.31M, a 208.47% decline year-over-year.
  • APTALIS PHARMA INC income tax expense (benefit) for the quarter ending 2011-09-30 was $9.35M.
  • APTALIS PHARMA INC income tax expense (benefit) for the quarter ending 2011-06-30 was -$2.06M.
  • APTALIS PHARMA INC income tax expense (benefit) for the quarter ending 2010-12-31 was $1.20M.
  • APTALIS PHARMA INC income tax expense (benefit) for fiscal 2011 was $4.03M, a 63.24% decline from fiscal 2010.
  • APTALIS PHARMA INC income tax expense (benefit) for fiscal 2010 was $10.95M.
  • APTALIS PHARMA INC income tax expense (benefit) for fiscal 2009 was -$24.08M.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 12 month
2011-12-31-$1.31M
10-Q · filed 2012-02-10
$8.04M
derived: sum of 2 quarters · filed 2012-02-10
$5.98M
derived: sum of 3 quarters · filed 2012-02-10
2011-09-30$9.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
$7.29M
derived: sum of 2 quarters · filed 2011-12-20
$4.03M
10-K · filed 2011-12-20
2011-06-30-$2.06M
10-Q · filed 2011-08-12
-$5.32M
10-Q · filed 2011-08-12
2010-12-31$1.20M
10-Q · filed 2012-02-10
-$4.00M
derived: sum of 2 quarters · filed 2012-02-10
-$9.45M
derived: sum of 3 quarters · filed 2012-02-10
2010-09-30-$5.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
-$10.66M
derived: sum of 2 quarters · filed 2011-12-20
$10.95M
10-K · filed 2011-12-20
2010-06-30-$5.45M
10-Q · filed 2011-08-12
$16.16M
10-Q · filed 2011-08-12
2009-09-30-$24.08M
10-K · filed 2011-12-20